The company AstraZeneca will stop marketing its vaccine against covid-19, Vaxzevria, starting tomorrow, May 7, 2024, in the European Union at its own request, as reported by the British-Swedish company in a statement.
The European Commission (EC) notified on March 27 that, at the request of the owner – AstraZeneca –, it is withdrawing the marketing authorization of the drug as of Tuesday.
“As multiple updated vaccines have been developed for Covid-19 variants, there is now a surplus of vaccines available. This has caused a decrease in demand for Vaxzervria, which is no longer manufactured or supplied,” the note states.
Experts point out that there is a “possible link” from the covid-19 vaccine developed by Oxford and AstraZeneca.
Photo:
The laboratory, which made the withdrawal request on March 5 before Brussels, congratulates itself on the role played by Vaxzevria in ending the pandemic. Along these lines, he points out that, “according to independent estimates, in the first year of use alone, more than 6.5 million lives were saved and more than 3 billion doses were supplied worldwide.”
It was the third vaccine to receive approval from European regulators, after those made by Pfizer/BioTech and Moderna.
EFE
More news
#AstraZenecas #covid #vaccine #longer #marketed #Europe